Keywords: gsk, pays, billion, settle, transfer, pricing, tax

GSK pays $3.1 billion to settle transfer pricing tax dispute with US IRS

Article | 18 September 2006

Print This

UK-headquartered GlaxoSmithKline has agreed to settle its drug transfer pricing tax dispute with the USA's Internal Revenue Service and will ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in